Sen. D'Amato considering bill to classify euphoria-producing supplements as drugs.
This article was originally published in The Tan Sheet
Executive Summary
SEN. D'AMATO CONSIDERING BILL TO CLASSIFY EUPHORIA-PRODUCING SUPPLEMENTS AS DRUGS in the wake of recent problems associated with ephedrine-containing stimulant products in Florida and New York. Florida is banning the sale of such products, as is New York's Nassau County. As currently written by Sen. Alfonse D'Amato (R-N.Y.), the draft bill would amend the FD&C Act to "clarify that any dietary supplement that claims to produce euphoria, heightened awareness or similar mental or psychological effects shall be treated as a drug."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning